Mayne Pharma Group Limited
MAYNF
$3.29
-$0.23-6.54%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 77.30M | 86.60M | 99.60M | 97.34M | 105.53M |
| Total Receivables | 130.70M | 146.43M | 138.56M | 135.43M | 135.56M |
| Inventory | 37.79M | 42.33M | 49.79M | 48.67M | 62.65M |
| Prepaid Expenses | -- | -- | 12.81M | 12.52M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.01M | 22.41M | 6.55M | 6.40M | 20.26M |
| Total Current Assets | 265.79M | 297.79M | 307.31M | 300.35M | 324.00M |
|
|
|||||
| Total Current Assets | 265.79M | 297.79M | 307.31M | 300.35M | 324.00M |
| Net Property, Plant & Equipment | 35.58M | 39.87M | 35.58M | 34.77M | 34.32M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 356.46M | 399.37M | 378.88M | 370.30M | 397.59M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 41.92M | 46.96M | 40.96M | 40.04M | 29.81M |
| Total Assets | 699.76M | 783.98M | 762.73M | 745.47M | 785.72M |
|
|
|||||
| Total Accounts Payable | 16.87M | 18.90M | 13.93M | 13.61M | 29.16M |
| Total Accrued Expenses | 105.64M | 118.35M | 120.00M | 117.28M | 122.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.93M | 25.69M | 2.55M | 2.49M | 2.36M |
| Total Finance Division Other Current Liabilities | 43.85M | 49.12M | 72.99M | 71.33M | 47.24M |
| Total Other Current Liabilities | 43.85M | 49.12M | 72.99M | 71.33M | 47.24M |
| Total Current Liabilities | 189.29M | 212.07M | 209.46M | 204.72M | 201.54M |
|
|
|||||
| Total Current Liabilities | 189.29M | 212.07M | 209.46M | 204.72M | 201.54M |
| Long-Term Debt | -- | -- | 21.11M | 20.63M | 20.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.74M | 1.95M | 2.24M | 2.19M | 2.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 232.60M | 260.59M | 226.88M | 221.75M | 188.21M |
| Total Liabilities | 423.62M | 474.61M | 459.69M | 449.29M | 412.32M |
|
|
|||||
| Common Stock & APIC | 758.50M | 849.79M | 816.80M | 798.32M | 834.30M |
| Retained Earnings | -600.01M | -672.22M | -629.84M | -615.59M | -572.82M |
| Treasury Stock & Other | 117.64M | 131.80M | 116.07M | 113.44M | 111.91M |
| Total Common Equity | 276.13M | 309.37M | 303.03M | 296.18M | 373.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 276.13M | 309.37M | 303.03M | 296.18M | 373.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 276.13M | 309.37M | 303.03M | 296.18M | 373.40M |
|
|
|||||